Involvement of tristetraprolin in transcriptional activation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase by insulin

Biochemical and Biophysical Research Communications

Volumn 420, Issue 1, 2012, Pages 178-182

  Ness, Gene C ^a   Edelman, Jeffrey L ^a   Brooks, Patricia A ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

AU rich RNA binding proteins; HMG CoA reductase transcription; In vivo electroporation; Insulin; SiRNA

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; INSULIN; LIVER ENZYME; SMALL INTERFERING RNA; TRISTETRAPROLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPORATION; ENZYME ACTIVATION; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RNA INTERFERENCE; TRANSCRIPTION INITIATION; TRANSCRIPTION TERMINATION;

ANIMALS; ELECTROPORATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN D; HYDROXYMETHYLGLUTARYL COA REDUCTASES; INSULIN; LIVER; MALE; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; TRANSCRIPTIONAL ACTIVATION; TRISTETRAPROLIN;

RATTUS;

EID: 84859106748     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.02.138     Document Type: Article

References (25)

1. Ness G.C., Chambers C.M. The diurnal variation of hepatic HMG-CoA reductase activity is due to changes in the level of immunoreactive protein. Arch. Biochem. Biophys. 1996, 327:41-44.
2. Ness G.C., Wiggins L., Zhao Z. Insulin increases hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA and immunoreactive protein levels in diabetic rats. Arch. Biochem. Biophys. 1994, 309:193-194.
3. Ness G.C., Zhao Z., Wiggins L. Insulin and glucagon modulate hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity by affecting immunoreactive protein levels. J. Biol. Chem. 1994, 269:29168-29172.
4. Lagor W.R., de Groh E.D., Ness G.C. Diabetes alters the occupancy of the hepatic 3-hydroxy-3-methylglutaryl-CoA reductase promoter. J. Biol. Chem. 2005, 280:36601-36608.
5. Keller R.K., Zhao Z., Chambers C.M., Ness G.C. Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver. Arch. Biochem. Biophys. 1996, 328:324-330.
6. Simonet W.S., Ness G.C. Transcriptional and posttranscriptional regulation of rat hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase by thyroid hormones. J. Biol. Chem. 1988, 263:12448-12453.
7. Stoecklin G., Tenenbaum S.A., Mayo T., Chittur S.V., George A.D., Baroni T.E., Blackshear P.J., Anderson P. Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J. Biol. Chem. 2008, 283:11689-11699.
8. Reynolds G.A., Basu S.K., Osborne T.F., Chin D.J., Gil G., Brown M.S., Goldstein J.L. HMG-CoA reductase: a negatively regulated gene with unusal promoter and 5' untranslated regions. Cell 1984, 38:275-285.
9. Carballo E., Lai W.S., Blackshear P.J. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 1998, 281:1001-1005.
10. C-Y. A. Chen, N. Xu, A-B. Shyu, Highly selective actions of HuR in antagonizing AU-rich element-mediated mRNA destabilization, Mol. Cell. Biol. 22 (2002) 7268-7278.
11. Masuda K., Marasa B., Martindale J.L., Halushka M.K., Gorospe M. Tissue- and age-dependent expression of RNA-binding proteins that influence mRNA turnover and translation. Aging 2009, 1:681-698.
12. Liang J., Lei T., Song Y., Yanes N., Qi Y., Fu M. RNA-destabilizing factor tristetraprolin negatively regulates NF-kB signaling. J. Biol. Chem. 2009, 284:29383-29390.
13. Schichl Y.M., Resch U., Hofer-Warbinek R., de Martin R. Tristetraprolin impairs NF-kB/p65 nuclear translocation. J. Biol. Chem. 2009, 284:29571-29581.
14. Lagor W.R., Heller R., de Groh E.D., Ness G.C. Functional analysis of the hepatic HMG-CoA reductase promoter by in vivo electroporation. Exp. Biol. Med. 2007, 232:353-361.
15. 3. Biochem. Biophys. Res. Commun. 2009, 385:466-471.
16. Lopez D., Abisambra Socarras J.F., Bedi M., Ness G.C. Activation of the hepatic LDL receptor promoter by thyroid hormone. Biochim. Biophys. Acta 2007, 1771:1216-1225.
17. Sanduja S., Blanco F.F., Dixon D.A. The roles of TTP and BRF proteins in regulated mRNA decay. Wiley Interdiscip. Rev. RNA 2010, 2:42-57.
18. Chen C.Y., Shyu A.B. Selective degradation of early-response-gene mRNAs: functional analyses of sequence features of the AU-rich elements. Mol. Cell. Biol. 1994, 14:8471-8482.
19. Lai W.S., Stumpo D.J., Blackshear P.J. Rapid insulin-stimulated accumulation of an mRNA encoding a proline-rich protein. J. Biol. Chem. 1990, 265:16556-16563.
20. Taylor G.A., Carballo E., Lee D.M., Lai W.S., Thompson M.J., Patel D.D., Schenkman D.I., Gilkeson G.S., Broxmeyer H.E., Hayes B.F., Blackshear P.J. Immunity 1996, 4:445-454.
21. Carballo E., Lai W.S., Blackshear P.J. Science 1998, 281:1001-1005.
22. Lai W.S., Carballo E., Strum J.R., Kennington E.A., Phillips R.S., Blackshear P.J. Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol. Cell Biol. 1999, 19:4311-4323.
23. Lai W.S., Parker J.S., Grisson S.F., Stumpo D.J., Blackshear P.J. Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficients fibroblasts. Mol. Cell Biol. 2006, 26:9196-9208.
24. Ogilvie R.L., Sternjohn J.R., Rattenbacher B., Vlasova I.A., Williams D.A., Hau H.H., Blackshear P.J., Bohjanen P.R. Tristetraprolin mediates interferon-gamma mRNA decay. J. Biol. Chem. 2009, 284:11216-11223.
25. Mermod N., O'Neill E.A., Kelly T.J., Tjian R. The proline-rich transcriptional activator of CTF/NF-1 is distinct from the replication and DNA binding domain. Cell 1989, 58:741-753.